Domov › Rakovina prsníka › North Carolina › Charlotte
Klinické štúdie Rakovina prsníka v meste Charlotte, NC
22 štúdií pre Rakovina prsníka hľadá účastníkov v zariadeniach v meste Charlotte a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
Prebieha náborFáza 2
- Levine Cancer, Charlotte
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
Prebieha náborFáza 1
- Carolina BioOncology Institute, LLC - Cancer Therapy and Research Center, Huntersville · 13 míľ odtiaľ
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Prebieha náborFáza 3
- Novant Health Cancer Institute ( Site 0019), Charlotte
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Prebieha náborFáza 3
- Levine Cancer Institute ( Site 0014), Charlotte
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Prebieha náborFáza 3
- Levine Cancer Institute, Charlotte
- Levine Cancer Institute, Charlotte
- Levine Cancer Institute, Charlotte
- a 7 ďalších
Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy
Prebieha nábor
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Prebieha nábor
- Atrium Levine Cancer Institute, Charlotte
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Prebieha náborFáza 3
- Clinical Trial Site, Charlotte
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
Prebieha náborFáza 3
- Atrium Health, Charlotte
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Prebieha náborFáza 3
- Oncology Specialists of Charlotte Pa, Charlotte
- Carolina Oncology Specialists, Charlotte
Utility of a Mobile Application for Young Women With Breast Cancer
Prebieha nábor
- Atrium Health Levine Cancer, Charlotte
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Prebieha náborFáza 1/2
- Research Site, Charlotte
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
Prebieha náborFáza 1/2
- Levine Cancer Institute, Charlotte
- Novant Health Cancer Institute, Charlotte
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Prebieha náborFáza 3
- Novant Health Cancer Institute, Charlotte
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Prebieha náborFáza 3
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
- Novant Health Presbyterian Medical Center, Charlotte
- Atrium Health Pineville/LCI-Pineville, Charlotte
- a 12 ďalších
E-Mindfulness Approaches for Living After Breast Cancer
Prebieha náborFáza 3
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
- Atrium Health Pineville/LCI-Pineville, Charlotte
- Levine Cancer Institute-SouthPark, Charlotte
- a 7 ďalších
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
Prebieha náborFáza 2
- GSK Investigational Site, Charlotte
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Prebieha náborFáza 1/2
- Carolina BioOncology Institute, Huntersville · 13 míľ odtiaľ
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Prebieha náborFáza 3
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
- Novant Health Presbyterian Medical Center, Charlotte
- Atrium Health Pineville/LCI-Pineville, Charlotte
- a 10 ďalších
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
Prebieha náborFáza 1/2
- Levine Cancer Institute (LCI)- Atrium Health, Charlotte
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Prebieha náborObservačná štúdia
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
- Atrium Health Pineville/LCI-Pineville, Charlotte
- Levine Cancer Institute-SouthPark, Charlotte
- a 8 ďalších
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Prebieha náborObservačná štúdia
- Atrium Health Levine Cancer Institute, Charlotte
- Novant Health Cancer Institute - Elizabeth, Charlotte
Štúdie Rakovina prsníka v iných mestách
- New York City, NY136 štúdií
- Houston, TX126 štúdií
- Boston, MA112 štúdií
- Nashville, TN81 štúdií
- Los Angeles, CA73 štúdií
- Edison, NJ68 štúdií
- St. Louis, MO64 štúdií
- Queens, NY64 štúdií
- Durham, NC64 štúdií
- Chicago, IL59 štúdií
- Philadelphia, PA56 štúdií
- Dallas, TX55 štúdií
Iné štúdie v Charlotte
- Rakovina (všetky typy)27 štúdií
- Mnohonásobný myelóm21 štúdií
- Nemalobunkový karcinóm pľúc19 štúdií
- Akútna myeloidná leukémia16 štúdií
- Obézita16 štúdií
- Nadváha15 štúdií
- Kolorektálny karcinóm13 štúdií
- Rakovina vaječníkov12 štúdií
- Srdcové zlyhanie11 štúdií
- Metastatická rakovina11 štúdií
- Skvamóznocelulárny karcinóm hlavy a krku10 štúdií
- CHOPN9 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.